167 related articles for article (PubMed ID: 29405336)
1. Ruthenium counterstaining for imaging mass cytometry.
Catena R; Montuenga LM; Bodenmiller B
J Pathol; 2018 Apr; 244(4):479-484. PubMed ID: 29405336
[TBL] [Abstract][Full Text] [Related]
2. Enhanced multiplexing in mass cytometry using osmium and ruthenium tetroxide species.
Catena R; Özcan A; Zivanovic N; Bodenmiller B
Cytometry A; 2016 May; 89(5):491-7. PubMed ID: 27018769
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL
JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159
[TBL] [Abstract][Full Text] [Related]
4. Cresyl Violet Stains Mast Cells Selectively: Its Application to Counterstaining in Immunohistochemistry.
Takahashi N; Tarumi W; Hamada N; Ishizuka B; Itoh MT
Zoolog Sci; 2017 Apr; 34(2):147-150. PubMed ID: 28397604
[TBL] [Abstract][Full Text] [Related]
5. Multicolor counterstaining for immunohistochemistry -- a modified Movat's pentachrome.
Petrovic A; Abramovic M; Mihailovic D; Gligorijevic J; Zivkovic V; Mojsilovic M; Ilic I
Biotech Histochem; 2011 Dec; 86(6):429-35. PubMed ID: 21091081
[TBL] [Abstract][Full Text] [Related]
6. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
[TBL] [Abstract][Full Text] [Related]
7. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
8. Quantification of cellular viability by automated microscopy and flow cytometry.
Sauvat A; Wang Y; Segura F; Spaggiari S; Müller K; Zhou H; Galluzzi L; Kepp O; Kroemer G
Oncotarget; 2015 Apr; 6(11):9467-75. PubMed ID: 25816366
[TBL] [Abstract][Full Text] [Related]
9. Synergistic tissue counterstaining and image segmentation techniques for accurate, quantitative immunohistochemistry.
Zehntner SP; Chakravarty MM; Bolovan RJ; Chan C; Bedell BJ
J Histochem Cytochem; 2008 Oct; 56(10):873-80. PubMed ID: 18574255
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study.
Savic S; Berezowska S; Eppenberger-Castori S; Cathomas G; Diebold J; Fleischmann A; Jochum W; Komminoth P; McKee T; Letovanec I; Jasarevic Z; Rössle M; Singer G; von Gunten M; Zettl A; Zweifel R; Soltermann A; Bubendorf L
Virchows Arch; 2019 Jul; 475(1):67-76. PubMed ID: 31127385
[TBL] [Abstract][Full Text] [Related]
11. A method for counterstaining tissues in conjunction with the glyoxylic acid condensation reaction for detection of biogenic amines.
Guidry G
J Histochem Cytochem; 1999 Feb; 47(2):261-4. PubMed ID: 9889262
[TBL] [Abstract][Full Text] [Related]
12. Romanowsky-Giemsa as a counterstain for immunohistochemistry: optimizing a traditional reagent.
Stefanović D; Stefanović M; Nikin Z
Biotech Histochem; 2013 Aug; 88(6):329-35. PubMed ID: 23651259
[TBL] [Abstract][Full Text] [Related]
13. [Quiz: Ready, study, score!].
Roussel H; Gibault L; Verkarre V; Lantuejoul S; Badoual C
Ann Pathol; 2017 Feb; 37(1):7-10. PubMed ID: 28161002
[No Abstract] [Full Text] [Related]
14. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
Owen D; Sheffield BS; Ionescu D; Churg A
Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
[TBL] [Abstract][Full Text] [Related]
15. [PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].
Lantuejoul S; Adam J; Girard N; Duruisseaux M; Mansuet-Lupo A; Cazes A; Rouquette I; Gibault L; Garcia S; Antoine M; Vignaud JM; Galateau-Sallé F; Sagan C; Badoual C; Penault-Llorca F; Damotte D;
Ann Pathol; 2018 Apr; 38(2):110-125. PubMed ID: 29571563
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
[TBL] [Abstract][Full Text] [Related]
17. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
19. Use of stains to detect fingermarks.
Becue A; Moret S; Champod C; Margot P
Biotech Histochem; 2011 Jun; 86(3):140-60. PubMed ID: 20121464
[TBL] [Abstract][Full Text] [Related]
20. Is immunohistochemistry always required to diagnose lung cancer?
Rossi G; Tiseo M; Cavazza A; Colby TV
Adv Anat Pathol; 2013 Sep; 20(5):327-33. PubMed ID: 23939149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
